Holen Sie sich die Stockscreener-App
18.16
1.10%
0.06
Grail Inc Aktie (GRAL) Neueste Nachrichten
180 Wealth Advisors LLC Takes $1.68 Million Position in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
GRAIL's Galleri Cancer Test Shows High Patient Satisfaction, Minimal Anxiety in Landmark Study - StockTitan
Trend Tracker for (GRAL) - Stock Traders Daily
Why a Roth IRA is the ‘holy grail’ retirement account—no matter your income - Yahoo Finance
Douglas Lane & Associates LLC Buys New Shares in Grail, Inc. (NASDAQ:GRAL) - MarketBeat
Liquid Biopsy Market Anticipated to Show Positive Growth - openPR
Grail to partner with Premier - LabPulse
Grail kicks off real-world study of multicancer blood test - LabPulse
Grail (NASDAQ:GRAL) Stock Price Down 7.4%Here's What Happened - MarketBeat
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Eastern Progress Online
Arden Theatre Company to Present World Premiere of Holy Grail of Memphis - TheaterMania.com
Short Interest in Grail, Inc. (NASDAQ:GRAL) Rises By 11.9% - MarketBeat
Grail (NASDAQ:GRAL) Trading Down 6.7%Should You Sell? - MarketBeat
Golden Grail Beverages Announces Strategic Update on UPDC Beverages Acquisition - GlobeNewswire
Disappointing week for GRAIL, Inc. (NASDAQ:GRAL) institutional investors who control 48% of the company - Yahoo Finance
Grail: What Lies Ahead After the Illumina Spin-Off - ETF Trends
Here's Why We're Watching GRAIL's (NASDAQ:GRAL) Cash Burn Situation - Simply Wall St
Stocks Showing Improving Market Leadership: GRAIL Earns 83 RS Rating - Investor's Business Daily
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Eastern Progress Online
Grail (NASDAQ:GRAL) Shares Gap DownHere's What Happened - MarketBeat
How the (GRAL) price action is used to our Advantage - Stock Traders Daily
Illumina And Grail In 2025? Grounds For Optimism, If Mistakes Aren't Repeated (ILMN) - Seeking Alpha
Grail (NASDAQ:GRAL) Shares Down 11.1%Time to Sell? - MarketBeat
GRAIL: Biotech Stock Targeting $100B Cancer Market - MSN
GRAIL to Present at J.P. Morgan Healthcare Conference 2024: Early Cancer Detection Pioneer Takes Stage - StockTitan
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Remedies After Illumina/GRAIL– The Thorny Question of Proportionality - PYMNTS.com
Grail Blood Test - KOIN.com
Grail (NASDAQ:GRAL) Sets New 52-Week HighHere's Why - MarketBeat
Grail, Inc. (NASDAQ:GRAL) Short Interest Up 15.9% in November - MarketBeat
Function Health Collaborates With GRAIL to Offer Multi-Cancer Early Detection Test Nationwide - The Eastern Progress Online
Grail: Lack Of Near Term Catalyst, Market Likely To Lose Interest Soon (NASDAQ:GRAL) - Seeking Alpha
Golden Grail Beverages buys US co-packer UPDC Beverages - Yahoo Finance
Golden Grail Beverages to acquire United Product Development Corp. - Food Business News
Golden Grail Beverages Announces the Acquisition of UPDC Beverages - GlobeNewswire
Golden Grail Beverages Expands Portfolio with Strategic Acquisition of Profitable Co-Packing Powerhouse UPDC - StockTitan
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4) - The Eastern Progress Online
Liquid Biopsy Market Poised for Substantial Growth (2024-2031) - openPR
Grail (NASDAQ:GRAL) Hits New 52-Week HighTime to Buy? - MarketBeat
GRAIL to Participate in Upcoming Investor Conferences - Kilgore News Herald
New blood test capable of screening for over 50 cancers available in Canada - Mugglehead
Function Health and GRAIL Collaborate to Make Multi-Cancer Early Detection Test More Accessible - HIT Consultant
Grail, Inc. (NASDAQ:GRAL) Short Interest Update - MarketBeat
GRAIL Awards 115K Shares in Equity Incentives to Attract Top Talent in Latest Hiring Push - StockTitan
Blood test that can screen for 50+ cancers now for sale in Canada, at $2,099 - CBC News
California startup finds early success with experimental blood test to detect many cancers - Martinsville Bulletin
Grail initiated at equal weight by Morgan Stanley - MSN
Grail initiated at equal weight by Morgan Stanley (NASDAQ:GRAL) - Seeking Alpha
Morgan Stanley cautious on GRAIL stock despite $100B market opportunity - Investing.com
Grail (NASDAQ:GRAL) Coverage Initiated by Analysts at Morgan Stanley - MarketBeat
Grail initiated with an Equal Weight at Morgan Stanley - TipRanks
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):